Liquidia net sales hit $130M as over 3,750 patients begin YUTREPIA therapy
Liquidia (NASDAQ:LQDA) posted net product sales of $129.9 million for the quarter ended March 31, 2026, a result driven entirely by the commercial success of YUTREPIA.
Liquidia (NASDAQ:LQDA) posted net product sales of $129.9 million for the quarter ended March 31, 2026, a result driven entirely by the commercial success of YUTREPIA.
FS KKR Capital (NYSE:FSK) reported net investment income of $0.42 per share for the first quarter of 2026, meeting internal expectations for core earnings.
Apogee Therapeutics (NASDAQ:APGE) ended the first quarter of 2026 with $1.3 billion in cash, cash equivalents, and marketable securities.
Airship AI (NASDAQ:AISP) posted net revenue of $6.3 million for the first quarter ended March 31, 2026, representing a 15% increase over the $5.5 million reported in the same period last year.
Atlanta Braves Holdings (NASDAQ:BATRA) posted total revenue of $72 million for the first quarter ended March 31, 2026, a 53% increase compared to the same period last year.
Sally Beauty Holdings (NYSE:SBH) posted consolidated net sales of $903 million for the quarter ended March 31, 2026, a 2.3% increase over the prior-year period.
Sharplink (NASDAQ:SBET) reported first-quarter 2026 revenue of $12.1 million, a dramatic increase from just $0.7 million in the prior-year period.
Uniti Group (NASDAQ:UNIT) reported consolidated revenue of $987.5 million for the first quarter ended March 31, 2026.
eXp World Holdings (NASDAQ:EXPI), the parent company of eXp Realty, posted first-quarter 2026 revenue of $1 billion, a 5% increase compared to the prior-year period.
Sonida Senior Living (NYSE:SNDA) posted resident revenue of $108.4 million for the first quarter of 2026, representing a 36.7% increase over the $79.3 million reported in the same period last year.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
